Aldeyra's Reproxalap Falls Short in Anterior Uveitis Trial

Aldeyra's Reproxalap Falls Short in Anterior Uveitis Trial

Submitted by admin on June 26, 2019 - 10:39am
Source: 
BioSpace
News Tags: 
Aldeyra Therapeutics
reproxalap
non-infectious anterior uveitis
Headline: 
Aldeyra's Reproxalap Falls Short in Anterior Uveitis Trial
snippet: 

Aldeyra Therapeutics reported that its reproxalap failed to meet its primary or secondary endpoints in noninfectious anterior uveitis.

Do Not Allow Advertisers to Use My Personal information